01/17/2025
7:15 AM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/13/2025
3:18 PM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/13/2025
7:44 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
01/10/2025
3:52 PM | Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/07/2025
8:02 PM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/06/2025
8:00 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
3:34 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:36 PM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/02/2025
3:45 PM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
12/19/2024
8:00 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SCHEDULE 13D/A | |
|
12/12/2024
7:01 AM | Revance Therapeutics (Subject)
| Form SC 14D9 | |
12/12/2024
6:15 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T | |
12/12/2024
5:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
4:16 PM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-C | |
12/09/2024
8:24 AM | Revance Therapeutics (Subject)
| Form SC14D9C | |
12/09/2024
8:17 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:23 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:27 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:02 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
8:24 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
12:20 PM | FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
10/25/2024
7:49 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
6:17 PM | GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
10/18/2024
8:29 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
9:08 AM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
6:32 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
6:15 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
4:01 PM | Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G | |
09/09/2024
9:40 AM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
09/05/2024
4:27 PM | Revance Therapeutics (Subject)
| Form SC14D9C | |
09/05/2024
3:45 PM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-C | |
08/13/2024
8:29 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-C | |
08/12/2024
4:18 PM | Revance Therapeutics (Subject)
| Form SC14D9C | |
08/12/2024
8:20 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
8:00 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:34 PM | Revance Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/02/2024
4:47 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:47 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:08 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
05/03/2024
7:42 AM | Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:43 AM | Coric Vlad (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:44 AM | Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:45 AM | Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:46 AM | Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:47 AM | Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:47 AM | Revance Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:34 PM | Jordan Erica (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
12:17 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
03/19/2024
5:43 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:44 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:44 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:45 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:16 AM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
5:10 AM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
5:13 AM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:33 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:44 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:39 AM | Revance Therapeutics (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Hollander David (Reporting)
Revance Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/29/2024
3:36 PM | Jordan Erica (Reporting)
Revance Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2024
3:07 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:55 PM | Palo Alto Investors LP (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
2:45 PM | Antara Capital LP (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
8:39 AM | Polar Capital Holdings Plc (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
12:58 PM | FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G | |
02/02/2024
3:46 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:48 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:45 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
10:10 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
10:11 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
